Charlotte Dubé, Ph.D.

Charlotte Dubé, Ph.D. has a diverse work experience in the field of preclinical studies and toxicology. Charlotte is currently working as a Principal Scientist in the Toxicology department at Providence Therapeutics since February 2023. Before that, they held various roles at Medicago starting in November 2013, including Scientific/Preclinical Studies, Manager/Preclinical Studies, and Director/Preclinical Studies. Charlotte worked at Syneos Health as a PK Scientist from October 2007 to November 2013, where they conducted and interpreted pharmacokinetic and statistical analysis within clinical and non-clinical studies. Prior to that, they worked as a Post-doctoral fellow at the Centre de recherche du CHUL, Unité d’ontogénie et reproduction, focusing on studying the COX-2 gene promoter in endometrial cancer and characterizing the activity of COX-2 promoters and the PDGFRα receptor in Leydig cells.

Charlotte Dubé, Ph.D. has a strong educational background with degrees in various fields. Charlotte began their education in 1996 at Université de Sherbrooke, where they completed their Bachelor's Degree in Microbiology in 1999. Charlotte then furthered their studies at Université Laval from 2000 to 2005 and earned a Ph.D. Degree in Physiology. In 2007, they pursued a short program in pharmaceutical development at Université Laval, enhancing their knowledge in the field. Continuing their education, in 2012 they attended SAS Institute Inc, focusing on SAS Programming Introduction and SAS Programming 1, acquiring skills in programming.